Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Pipeline
Cancer Program
Fibrosis Program
Clinical Trial
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
Contact Us
Contact Us
Email Alerts
Announcements and Reports
Home
>
Announcements and Reports
>
ASX Announcements
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
ASX Announcements
Filter by Year:
2023
2022
2021
2020
2019
2018
17-Dec-2020
Shareholder Update - 2020 Review
2-Dec-2020
Amplia Receives $0.53m R&D Tax Incentive
27-Nov-2020
Appendix 4D and Financial Report Half Year Ended 30 Sep 2020
24-Nov-2020
Appendix 2A - Allot Shares upon Exercise of Options
2-Nov-2020
Notice ASX LR 3.11.2 - Change of Exercise Price of Options
29-Oct-2020
ATX - Sep 2020 Quarter Activities and Cashflow Reports
21-Oct-2020
Amplia Presentation to Reach Market Services - Meet the CEO
20-Oct-2020
Response to ASX Price Query
8-Oct-2020
First Human Dose in Phase 1 Clinical Trial of AMP945
18-Sep-2020
Change of Director's Interest Notice - Dr. Warwick Tong
1
2
3
4
5
6
7
Next
